About Etogesic (Etodolac for Dogs) - Pain Reliever An Anti-Inflammatory Dog Arthritis Medicine

Etogesic (Etodolac) is a non-narcotic, non-steroidal, anti-inflammatory drug (NSAID), is a prescribed medication in managing fever, pain and inflammation caused by osteoarthritis or hip dysplasia in dogs. Like all NSAID medications, the mode of action of EtoGesic is the inhibition of cyclo-oxygenase activity by hindering the secretion of the body chemicals, prostaglandins. The anti-inflammatory, anti-pyretic, and analgesic properties of Etogesic makes it a trusted medication for pain management in dogs.

Etogesic (Etodolac) is contraindicated in animals with a proven history of allergy to etogesic or other NSAIDs. This medication should not be used in dogs with liver, heart, or blood abnormalities or those with ulcers and other gastrointestinal conditions. Dogs on a fairly long course of EtoGesic should be monitored periodically to ensure that the animal is not developing intolerance to the medication. EtoGesic could interact with other NSAIDs like aspirin, or cortisone based drugs. This medication must not be administered in dogs less than 10 pounds or in nursing and pregnant animals as its safety has not been proved. EtoGesic should never be tried on cats.

Etogesic (Etodolac) could be given with or without food, however too much food is found to slacken the process of drug absorption. The tablets come in varying strengths ranging from 50 mg, 200 mg, 300 mg, 400 mg and 500 mg tablets. The recommended initial dosage of Etogesic is 5 to 6 mg per pound (10 to 15 mg/kg) once daily, which should never go above 6.8mg/pound. When a satisfactory clinical response is obtained, the daily dose level should be reduced to the minimum effective level according to the veterinarian’s advice.

Etogesic (Etodolac) is normally well tolerated by dogs, when used under a licensed veterinarian. But, some animals might develop side effects such as vomiting, diarrhea, lethargy, bloody stools, jaundice or lack of appetite while they are being treated with EtoGesic. In such cases, treatment should be stopped and alternate treatment plans adopted in consultation with the veterinarian.

Etodolac, Lodine (Wyeth-Ayerst)